08/03/2021 12:02
Clarín.com
Society
Updated 08/03/2021 12:02
The Russian Direct Investment Fund (RDIF) and the local Richmond laboratories announced on Tuesday the putting into circulation, this week, of
the Sputnik V vaccine produced in Argentina
.
Samples of the vaccine produced in the country
successfully passed quality control
at the Gamaleya Center, they said in a statement.
At the same time, the RDIF and Richmond announced that Argentina will have
more than 3 million doses of the second component of Sputnik V
manufactured locally in August.
The first 150 thousand doses, they pointed out, will go into circulation this week.
"As planned, Laboratorios Richmond will be able to produce more than 3 million doses of the second component of the Sputnik V vaccine in August. This week, the company will begin shipping the vaccine produced in Argentina to the government of the country, including
150,000 doses of the second component.
, to protect the population against the coronavirus, "the letter details.
Kirill Dmitriev, executive director of the RDIF, considered that this could "
accelerate the rate of vaccination
and reduce logistics costs and drug delivery time."
Last June, Richmond confirmed that it had completed the production of the first 448,625 doses of the Sputnik V vaccine against the coronavirus in its laboratory in Pilar and that it
had sent samples to Russia
for the Gamaleya Institute to approve before they are applied in the country.
Only 26 percent of those who were vaccinated with the Russian have the complete scheme.
Photo: Rafael Mario Quinteros
Vaccination with the Russian drug, the first used in the country, began in Argentina on December 29 of last year.
However,
there are delays in component 2 deliveries
.
Until this Monday, 9,375,670 doses of component 1 and
only 2,493,160 doses of 2
were applied in the country
.
In other words, only 26% of those who were vaccinated with Sputnik V have the complete scheme.
Among the immense group of inoculated with a dose throughout the country, there are those who this week will be
four months waiting for
the second puncture.
Vaccine combination
On the other hand, a few hours after the first results of the trials of the combination of the Sputnik V vaccine with those of AstraZeneca and Sinopharm are known, carried out by the Ministry of Health of the Nation together with several provinces, the Minister of Buenos Aires health, Nicolás Kreplak, announced this Tuesday that, if the expected efficacy is confirmed, those who have received the first dose of the Russian formula will be able to choose to combine vaccines to complete their scheme or wait for the arrival of doses of component 2 of Sputnik V.
The first results of the vaccine combination research in the City of Buenos Aires have so far shown that the Sputnik V - Astrazeneca option has a better performance than Sputnik V - Sinopharm, according to an advance that Clarín was able to access.
These are preliminary results and sources from the Buenos Aires Ministry of Health do not rule out that Sinopharm can also be used as a second dose in the absence of the Russian.
To have more results you will have to wait a few days.
LGP
Look also
Sputnik V: there are vaccinated people who wait 4 months for the second dose
The Province will choose between combining vaccines or waiting for the second component of Sputnik